TY - JOUR
T1 - Bioactive peptides
T2 - Conformational studies of [TYR4] cyclolinopeptide A
AU - Saviano, Michele
AU - Rossi, Filomena
AU - Filizola, Marta
AU - Isernia, Carla
AU - Di Blasio, Benedetto
AU - Benedetti, Ettore
AU - Pedone, Carlo
AU - Siemion, Ignacy Z.
AU - Pedyczak, Artur
PY - 1995/10
Y1 - 1995/10
N2 - The solid state conformational analysis of [Tyr4] cyclolinopeptide A has been carried out by x‐ray diffraction studies. The crystal structure of the monoclinic form, grown from a dioxane‐water mixture [a = 9.849 (5) Å, b = 20.752 (4) Å, c = 16.728 (5) Å, β = 98.83 (3)°, space group P21, Z = 2], shows the presence of five intramolecular N‐H OC hydrogen bonds, with formation of one C17 ring structure, one α‐turn (C13), one inverse γ‐turn (C7), and two β‐turns (C10, one of type III and one of type 1). The Pro1‐Pro2 peptide unit is cis (ω = 5°) all others are trans. The structure is almost superimposable with that of cyclolinopeptide A. The rms deviation for the atoms of the backbones is on the average 0.33 Å. © 1995 John Wiley & Sons, Inc.
AB - The solid state conformational analysis of [Tyr4] cyclolinopeptide A has been carried out by x‐ray diffraction studies. The crystal structure of the monoclinic form, grown from a dioxane‐water mixture [a = 9.849 (5) Å, b = 20.752 (4) Å, c = 16.728 (5) Å, β = 98.83 (3)°, space group P21, Z = 2], shows the presence of five intramolecular N‐H OC hydrogen bonds, with formation of one C17 ring structure, one α‐turn (C13), one inverse γ‐turn (C7), and two β‐turns (C10, one of type III and one of type 1). The Pro1‐Pro2 peptide unit is cis (ω = 5°) all others are trans. The structure is almost superimposable with that of cyclolinopeptide A. The rms deviation for the atoms of the backbones is on the average 0.33 Å. © 1995 John Wiley & Sons, Inc.
UR - http://www.scopus.com/inward/record.url?scp=0029164916&partnerID=8YFLogxK
U2 - 10.1002/bip.360360408
DO - 10.1002/bip.360360408
M3 - Article
C2 - 7578940
AN - SCOPUS:0029164916
SN - 0006-3525
VL - 36
SP - 453
EP - 460
JO - Biopolymers
JF - Biopolymers
IS - 4
ER -